The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population

References

• Ozhan H, Aydin M, Yazici M, Yazgan O, Basar C, Gungor A, Onder E. Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets 2010; 21: 29–32
   PubMed Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity?. Clin Appl Thromb Hemost 2003; 9: 177–190
   PubMed Web of Science ®Google Scholar
• Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared tostable angina or non-cardiac chest pain. Eur Heart J 1998; 19: 80–84
   PubMed Web of Science ®Google Scholar
• Jagroop IA, Mikhailidis DP. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2003; 120: 169–170
   PubMed Web of Science ®Google Scholar
• Bernadette Moore. J. Non-alcoholic fatty liver disease: The hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc 2010; 69: 211–220
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722–728
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50: 1844–1850
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917–923
   PubMed Web of Science ®Google Scholar
• Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008; 49: 608–612
   PubMed Web of Science ®Google Scholar
• Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263–2271
   PubMed Web of Science ®Google Scholar
• Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388–1393
   PubMed Web of Science ®Google Scholar
• Schwimmer JB, Pardee PE, Lavine JE, et al. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008; 118: 277–283
   PubMed Web of Science ®Google Scholar
• Pacifico L, Cantisani V, Ricci P, et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008; 63: 423–427
   PubMed Web of Science ®Google Scholar
• Sattar N, Scherbakova O, Ford I, O’Reilly DS, Stanley A, Forrest E, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 2004; 53: 2855–860
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino RB, Jr, Haffner SM. Liver markers and development of the metabolic syndrome. The Insulin Resistance Atherosclerosis Study. Diabetes 2005; 54: 3140–3147
   PubMed Web of Science ®Google Scholar
• Robinson SD, Harding SA, Cummins P, et al. Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease. Platelets 2006; 17: 158–162
   PubMed Web of Science ®Google Scholar
• Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate?. Hematology 2006; 11: 317–339
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981–982
   PubMed Web of Science ®Google Scholar
• Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An eleven-year follow-up study. Am J Gastroenterol 2009; 104: 861–867
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: A tale of two ‘hits’?. Gastroenterology 1998; 114: 842–845
   PubMed Web of Science ®Google Scholar
• Jurcut R, Arsenescu I, Puşcariu T, et al. Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina?. Rom J Intern Med 2005; 43: 199–209
   PubMedGoogle Scholar
• Lefer AM, Ma XL. Cytokines and growth factors in endothelial dysfunction. Crit Care Med 1993; 21: S9–14
   Web of Science ®Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMed Web of Science ®Google Scholar
• Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocr 2006; 29: 81–90
   Google Scholar
• Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473–480
   PubMed Web of Science ®Google Scholar
• Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191: 235–240
   PubMed Web of Science ®Google Scholar
• Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: The plot thickens. Diabet Med 2007; 24: 1–6
   PubMed Web of Science ®Google Scholar
• Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006; 291: E282–290
   Web of Science ®Google Scholar
• Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis. Atherosclerosis 2010; 211: 182–186
   PubMed Web of Science ®Google Scholar
• Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007; 120: 245–250
   PubMed Web of Science ®Google Scholar
• Muscari A, De Pascalis S, Cenni A, et al. Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008; 99: 1079–1084
   PubMed Web of Science ®Google Scholar
• Pizzulli L, Yang A, Martin JF, Lüderitz B. Changes in platelet size and count in unstable angina compared to stable angina or noncardiac chest pain. Eur Heart J 1998; 19: 80–84
   PubMed Web of Science ®Google Scholar
• Kong AP, Choi KC, Cockram CS, Ho CS, Chan MH, Ozaki R, et al. Independent associations of alanine aminotransferase (ALT) levels with cardiovascular risk factor clustering in Chinese adolescents. J Hepatol 2008; 49: 115–122
   PubMed Web of Science ®Google Scholar
• Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: Determinants and association with mortality from ischaemic heart disease and all causes. Am J Epidemiol 1995; 142: 699–708
   PubMed Web of Science ®Google Scholar
• Ruttmann E, Brant LJ, Concin H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112: 2130–2137
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157–161
   PubMed Web of Science ®Google Scholar